GandL Healthcare Advisors Revenue and Competitors

Warren, NJ USA

Location

N/A

Total Funding

Government

Industry

Estimated Revenue & Valuation

  • GandL Healthcare Advisors's estimated annual revenue is currently $36M per year.(i)
  • GandL Healthcare Advisors's estimated revenue per employee is $140,000

Employee Data

  • GandL Healthcare Advisors has 257 Employees.(i)
  • GandL Healthcare Advisors grew their employee count by 34% last year.

GandL Healthcare Advisors's People

NameTitleEmail/Phone
1
Chief Technology OfficerReveal Email/Phone
2
VP and Head CommercializationReveal Email/Phone
3
VP Advisory PracticeReveal Email/Phone
4
VP Regulatory AffairsReveal Email/Phone
5
SVP, Asia Pacific and EuropeReveal Email/Phone
6
Regulatory Affairs OfficerReveal Email/Phone
7
VP Regulatory Affairs & Business Development US West CoastReveal Email/Phone
8
VP, Pharmaceutical CMCReveal Email/Phone
9
VP Regulatory Affairs and Quality AssuranceReveal Email/Phone
10
VP Corporate DevelopmentReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$15M23212%N/AN/A
#2
$1.7M4310%N/AN/A
#3
$3.5M956%N/AN/A
#4
$7.5M248-8%N/AN/A
#5
$243.7M17413%N/AN/A
#6
$7.5M695%N/AN/A
#7
$75M111614%N/AN/A
#8
$3.5M46-8%N/AN/A
#9
$3.5M5920%N/AN/A
#10
$3.5M859%N/AN/A
Add Company

What Is GandL Healthcare Advisors?

Are you ready to be best in class?At G&L, we use subject matter expertise and decades of experience gained in every aspect of Regulatory Affairs, Quality Assurance and Clinical Development to meet the challenges faced by healthcare companies globally.From product development and submissions to company-wide change management, we design, implement, and run quality, results-focused outcomes for everyone we work with.

keywords:N/A

N/A

Total Funding

257

Number of Employees

$36M

Revenue (est)

34%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$79.2M268-3%$14M
#2
$99.5M27414%N/A
#3
$76.5M27724%N/A
#4
$39.6M28333%N/A
#5
$55M284-29%$400M